Merck & Co., Inc. (NYSE:MRK)
Q3 2017 Earnings Call
October 27, 2017 8:00 am ET
Executives
Teri Loxam - Merck & Co., Inc.
Kenneth C. Frazier - Merck & Co., Inc.
Robert M. Davis - Merck & Co., Inc.
Adam H. Schechter - Merck & Co., Inc.
Roger M. Perlmutter - Merck & Co., Inc.
Analysts
Andrew S. Baum - Citigroup Global Markets Ltd.
Alexander Man - Sanford C. Bernstein & Co. LLC
Chris Schott - JPMorgan Securities LLC
David R. Risinger - Morgan Stanley & Co. LLC
Steve Scala - Cowen and Co. LLC
Alex Arfaei - BMO Capital Markets (United States)
Gregg Gilbert - Deutsche Bank Securities, Inc.
Vamil K. Divan - Credit Suisse Securities (NYSE:USA) LLC
Geoffrey Meacham - Barclays Capital, Inc.
Umer Raffat - Evercore ISI
Jami Rubin - Goldman Sachs & Co. LLC
Operator
Good morning. My name is Darla, and I will be your conference operator today. At this time, I'd like to welcome everyone to Merck's Q3 2017 Sales and Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. Thank you.
I would now like to turn the call over to Teri Loxam. Please go ahead.